Runs R&D at Small Pharma to lead this conversation. Ellen has been with Small Pharma since the start and is a bit of a superwoman having worn a variety of hats when they were still a small startup team. Ellen also has a Ph.D. from Imperial in molecular biology and studied Biological Sciences at Oxford. Small Pharma, the company leading the world’s first DMT clinical trials, has announced it has dosed its first patient in phase IIA DMT-assisted therapy clinical trial. The innovative program, the first of its kind, remains on track for topline results by H1 2022. Small Pharma is one of the few psychedelic companies working with DMT, a naturally occurring psychedelic tryptamine found in plants and the brain of mammals. Scientific evidence suggests DMT offers the potential for rapid-acting and long-lasting antidepressant effects.
Related Episodes
Ellen James Shares Insights From the World's First DMT Clinical Trial
In this episode, Joy sits down with Ellen James, Director of Research and Development at Small Pharma, a neuro-pharmaceutical company that is currently developing a psychedelic-assisted therapy for the treatment of mental health conditions. Small Pharma is one of the few psychedelic companies workin...